FDA Clearance Tracker · P250008-S001
Claire OCT System
Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Aug 10, 2026
Approved
Time to decision
150 days
Received Mar 13, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P250008-S001
- Device name
- Claire OCT System
- Applicant
- Perimeter Medical Imaging Ai, Inc.
- Applicant location
- Toronto
- Received
- Mar 13, 2026
- Decided
- Aug 10, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P250008
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
Approval for a manufacturing site located at RBC Development, LLC (dba Vantage MedTech / RBC Medical Innovations), located at 17100 W 118th Terrace, Olathe, KS 66061, performing cart assembly, consumable (Specimen Immobilizer) assembly, receiving inspection, and tech services and laboratory functions at this facility.
Source documents
Other decisions for Perimeter Medical Imaging Ai, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Claire OCT SystemBreakthroughPMA
P250008 · Decided Mar 3, 2026 · 355 days after receipt
Device type: OCT imaging system with AI/ML software for adjunctive detection of breast cancer (SHH) · General & Plastic Surgery
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.